Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy |
Etiz, Durmus
(Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University)
Bayman, Evrim (Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University) Akcay, Melek (Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University) Sahin, Bilgehan (Department of Radiation Oncology, School of Medicine, Eskisehir Osmangazi University) Bal, Cengiz (Department of Biostatistics, School of Medicine, Eskisehir Osmangazi University) |
1 | Ahn SJ, Kahn D, Zhou S, et al (2005). Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys, 61, 335-47. DOI ScienceOn |
2 | Bradley J, Deasy JO, Bentzen S, Naqa IE (2004). Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys, 58, 1106-13. DOI ScienceOn |
3 | Caglar HB, Othus M, Allen AM (2010). Esophagus in- field: a new predictor for esophagitis. Radiother Oncol, 97, 48-53. DOI ScienceOn |
4 | De Ruysscher D, Van Meerbeeck J, Vandecasteele K, et al (2012). Radiation-induced oesophagitis in lung cancer Patients : Is susceptibility for neutropenia a risk factor? Strahlenther Onkol, 188, 564-7. DOI ScienceOn |
5 | Dorr W, Hendry JH (2001). Consequential late effects in normal tissues. Radiother Oncol, 61, 223-31. DOI ScienceOn |
6 | Emami B, Lyman J, Brown A et al (1991). Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21, 109-22. |
7 | Hirota S, Tsujino K, Hishikawa Y, et al (2001). Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol, 58, 273-8. DOI ScienceOn |
8 | Huang EX, Bradley JD, Naga IE, et al (2012). Modeling the risk of radiation-Induced acute esophagitis for combined Washington University and RTOG Trial 93-11 lung cancer patients. Int J Radiat Oncol Biol Phys, 82, 1674-9. DOI ScienceOn |
9 | ICRU Report 62 (1999). International Commision on Radiation Units and Measurements:Prescribing, recording and reporting photon beam therapy, Bethesda. |
10 | Lara PN Jr, Chansky K, Shibata T, et al (2010). Common arm comparative outcomes analysis of phase 3 trials of cisplatin+irinotecan versus cisplatin+etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124. Cancer, 116, 5710-5. DOI ScienceOn |
11 | Maguire P, Sibley G, Zhou SM, et al (1999). Clinical and dosimetric predictors of radiation-Induced esophageal toxicity. Int J Radiat Oncol Biol Phys, 45, 97-103. DOI ScienceOn |
12 | Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M (2004). Predictors of acute esophagitis in patients with non small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys, 60, 1106-12. DOI ScienceOn |
13 | Singh AK, Lockett MA, Bradley JD (2003). Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys, 55, 337-41. DOI ScienceOn |
14 | Qiao WB, Zhao YH, Zhao YB, Wang RZ (2005) Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World J Gastroenterol, 11, 2626-9. DOI |
15 | Rodriguez N, Algara M, Foro P, et al (2009). Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys, 73, 810-7. DOI ScienceOn |
16 | Rose J, Rodrigues G, Yaremko B, Lock M, D'Souza D (2009). Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol, 91, 282-7. DOI ScienceOn |
17 | Soo RA, Kawaguchi T, Loh M, et al (2012). Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy. Future Oncol, 8, 451-62. DOI ScienceOn |
18 | Takeda K, Nemoto K, Saito H, et al (2005). Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys, 62, 626-9. DOI ScienceOn |
19 | Werner-Wasik M, Scott C, Graham ML, et al (1999). Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys, 44, 327-31. DOI ScienceOn |
20 | Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curan W (2000). Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys, 48, 689-96. DOI ScienceOn |
21 | Court L, Wang J, Lin S (2012). SU-E-T-250:Dose-Response curves for the esophagus. Med Phys, 39, 3761. |
22 | Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks LB (2010). Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys ,76, 86. DOI ScienceOn |
![]() |